Increasing Prevalence of Chronic Disorders and Initiatives to Develop Flying Ambulance for Medical Emergency Use to Augment Growth of Air Ambulance Services Market

 

Increasing prevalence of chronic disorders is expected to propel growth of the global air ambulance services market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

Emergence of Covid-19 is expected to propel growth of the global air ambulance services market. For instance, globally, as of 6:51pm CET, 3 January 2021, there have been 83,322,449 confirmed cases of COVID-19, including 1,831,412 deaths, reported to the World Health Organization.

High cost of air ambulance services and the relative low adoption of these services in emerging economies compared to developed countries is expected to hinder growth of the global air ambulance services market.

Among regions, North America is expected to witness significant growth in the global air ambulance services market, owing to launch of new services. For instance, in September 2020, WellSpan Health, an integrated health system in the U.S., and Air Methods, a leading air medical service in the U.S., jointly launched a new medical helicopter service to improve access to emergency air transport services for the most critically injured or sick patients.

Asia Pacific is also expected to witness significant growth in the global air ambulance services market, owing to increasing initiatives to develop a flying ambulance for medical emergency use. For instance, in August 2020, EHang Holdings Limited, an autonomous aerial vehicle technology platform company, announced that it has been selected to join Ambular, an international project endeavoring to develop a flying ambulance for medical emergency use.

Competitive Analysis

Major players operating in the global air ambulance services market include, Air Methods Corporation, Deccan Charters, Scandinavian Air Ambulance, Air Ambulance Specialists, Air Charter Service, Envision Healthcare Companies, Falck Danmark A/S, AMR Air Ambulance, AirMed International, Air Methods, and Express Aviation Services.

Major players operating in the global air ambulance services market are focused on adopting partnership strategies to enhance their market share. For instance, in August 2020, Air Methods partnered with Borrego Health, a Federally Qualified Health Center in the U.S., to start a new Mercy Air base at the Borrego Medical Clinic in Borrego Springs, California, U.S.

Rise in the consumer electronic products is escalating the demand for epoxy curing agents

 

Epoxy is a compound consisting of two hydrogen atoms bonded together via an electrochemical reaction. When the hydrogen atoms are bonded together, they give rise to a clear solution containing a variety of hydroxyl groups and one or more esters. Epoxy resin is utilized in abrasive applications and other chemical bonding operations to create a protective layer against corrosion, temperature change, oxidation, and other conditions. A high-quality epoxy resin can withstand extreme temperatures and resist abrasive loads. It is used for floor coatings, ceiling and wall coverings, bonding to plastics and rubber components, sealing materials for aquariums, food packaging, medical applications, and many other applications. Its chemical and physical properties make it highly useful for bonding, vaporizing, hardening, and coating materials.

Growing demand for epoxy curing agents across various applications such as wind energy, coatings, electrical & electronics, adhesive, construction, and composite is fueling the market growth. Rise in the construction industry due to increasing investment in the construction industry across developing and the developed region is expected to augment the market growth of the epoxy curing agents. Moreover, the growing demand for consumer electronic products is again projected to foster the market growth of the epoxy curing agents. Furthermore, the growing demand for coatings, composites, and adhesives is also projected to propel the market growth of the epoxy curing agent.

The Asia Pacific is expected to exhibit significant growth over the forecast period and this is attributed to the high demand for consumer electronic products in the region. According to the India Brand Equity Foundation, the Indian appliance and consumer electronics (ACE) market reached Rs. 76,400 crore (US$ 10.93 billion) in 2019. Appliances and the consumer electronics industry is expected to double to reach Rs. 1.48 lakh crore (US$ 21.18 billion) by 2025.

Key Developments:

In March 2020, Gabriel Performance Products (“Gabriel”), a U.S.-based specialty chemicals company serving the coatings, adhesives, and composite markets, announces the launch of a new epoxy curing agent, VERSACURE® RAC 9040 and RAC 9010UV for clear coatings, tabletop and countertop applications.
In October 2018, Bitrez Ltd has launched the world’s first Ketamine epoxy curing agents to combat the withdrawal of conventional grades prohibited in Europe under REACH regulations. The new grades have been added to their already extensive Curamine cross-linking agents for the epoxy resin product range.
In April 2020, Hexion Inc. has launched both a new lower yellowing epoxy system for concrete protection and a unique amine curing agent to help coatings manufacturers meet lower indoor air emissions requirements while also reducing costs.

High Prevalence of Ovarian Cancer to Augment Growth of Ovarian Cancer Drugs Market

 

Treatment for ovarian cancer normally involves a combination of chemotherapy and surgery. Chemotherapy uses special medicines to kill or shrink the cancer cells. Drugs used to treat ovarian cancer are considered systemic therapies.

Market Dynamics

High prevalence of ovarian cancer is expected to propel growth of the ovarian cancer drugs market. For instance, the National Cancer Institute estimated around 22,530 new cases of ovarian cancer and 13,980 deaths due to the disease in the U.S. in 2019. Moreover, availability of effective drugs is also expected to aid in growth of the market. For instance, in October 2020, according to a new research conducted by scientists at the Fox Chase Cancer Center and Gynecologic Oncology Group, a targeted medication known as bevacizumab, also going by the name Avastin, may delay the development of advanced ovarian cancer.

R&D in ovarian cancer is expected to offer lucrative growth opportunities for players in the ovarian cancer drugs market. For instance, in June 2020, a study presented via the virtual Society of Gynecologic Oncology 2020 Annual Meeting on Women's Cancer, reported examining a large clinical dataset of low-grade serous ovarian cancer through the Ovarian Cancer Association Consortium, with the primary goal of identifying factors that affect survival.

However, development of vaccines is expected to hinder growth of the ovarian cancer drugs market. For instance, in December 2020, Anixa Biosciences entered into a license agreement with Cleveland Clinic for exclusive, world-wide rights to an ovarian cancer vaccine technology.

Major players operating in the ovarian cancer drugs market are focused on R&D to expand their product portfolio. For instance, in December 2020, TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, announced positive interim data from the ongoing Phase 1 portion of the TC-210 Phase 1/2 clinical trial for mesothelin-expressing solid tumors in ovarian cancer.

Competitive Analysis

Major players operating in the ovarian cancer drugs market include, Bristol Myers Squibb Company, Eli Lilly and Company, IMV Inc., TCR2 Therapeutics Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc., Novogen, Inc., Genentech Inc., Aetera Zenteris Inc., Boehringer Ingelheim GmbH, and F. Hoffman-La Roche Ltd.

Major players operating in the ovarian cancer drugs market are focused on R&D to expand their product portfolio. For instance, in December 2020, IMV Inc., a clinical-stage biopharmaceutical company, reported updated clinical and translational data from DeCidE1, its Phase 2 clinical study evaluating the safety and efficacy of DPX-Survivac with intermittent low-dose cyclophosphamide (CPA) in patients with recurrent, advanced platinum-sensitive and platinum-resistant ovarian cancer.

Ongoing trend of go-green is boosting sale of renewable chemicals

 

Growing preferences for eco-friendly products coupled with the low-cost of the feedstock is driving the market growth of renewable chemicals. Increasing prices of fossil fuels and the need to reduce greenhouse emissions are again contributing to the market growth of renewable chemicals. Moreover, the growing cultivation of corn and sugarcane as they are the ideal substitute for renewable chemicals is further projected to accelerate the market growth over the forecast period. According to the International Sugar Organization, sugarcane, on average, accounts for nearly 80% of global sugar production. Between 2001 and 2018, world sugar consumption increased from 123.454 mln tones to 172.441 mln tones, the equivalent to average annual growth of 2.01%. Also, the growing popularity of biopolymers derived from renewable feedstock such as corn and sugarcane is further anticipated to foster the market growth of renewable chemicals over the forecast period.

North America is expected to gain significant growth over the forecast period and this is attributed to increasing initiatives by the government to promote the use of eco-friendly products. For instance, the US Environmental Protection Agency (EPA) has made it compulsory for the manufacturer of gasoline to use a percentage of renewable ethanol, as ethanol significantly reduces greenhouse gas emissions.

Key Developments:

In July 2020, Praj Industries foray into developing technologies to produce bio-based renewable chemicals and materials (RCM). RCM produced from bio-based feedstocks are sustainable alternatives to products made from fossil resources.
In October 2020, Perstorp announced the launch of the first partly renewable carboxylic acids - 2-Ethylhexanoic Acid Pro and Valeric Acid Pro. 2-EHA Pro is based on 25% renewable raw materials, and Valeric Acid Pro contains 20% renewable content.
In October 2019, Clariant has partnered with renewable hydrocarbon producer Neste to offer a wide range of additives based on mass balance certified ethylene and propylene from renewable feedstock, which reliably delivers both high performance and sustainability.
In August 2018, Braskem launches a new renewable resin made from sugarcane in Allbirds shoes. It is designed for the application such as footwear, automotive, transportation, and others.

Oilfield Stimulation Chemicals Market is Growing Rapidly with BASF SE expanding its production capacity with the installation of enhanced oil recovery polymer injection plants in Argentina

 

Oilfield Chemicals have been on the rise over the past few years. This steady increase in popularity is largely due to the fact that the average cost of starting an oilfield business is much less than the cost of starting an operations-based business such as a hospital or dentist's office. The average cost of starting an oilfield business is less than half of what it would cost to have the same type of equipment and supplies installed in your own business. There are also many government and private grants available to help new small businesses get started.

Growing deep drilling operations is expected to drive growth of the global oilfield stimulation chemicals market. Many oil and gas corporations worldwide are focused on oil drilling activities with rising investment in the oil & gas sector. For instance, in December 2020, ExxonMobil Corporation and PETRONAS discovered hydrocarbons at Sloanea-1 exploration well on Block 52 offshore Suriname. Furthermore, in October 2020, ExxonMobil made its final investment of US$ 9 billion in Payara field offshore development in Guyana. As a result of rising deep drilling operations across the globe, the demand for stimulation chemicals for hydraulic fracturing, acid fracking, matrix acidization, and other processes. Hence, these factors are expected to drive growth of the global oilfield stimulation chemicals market. Furthermore, increasing crude oil production is expected to propel the global oilfield stimulation chemicals market growth in the near future.

Low prices of crude oil and stringent government regulations combined with high environmental risk are expected to hamper the global oilfield stimulation chemicals market growth in the near future. However, the use of biopolymer in the stimulation and discovery of new oilfields in Latin America and Africa can provide major business opportunities in the near future. Among regions, North America is expected to witness significant growth in the global oilfield stimulation chemicals market. This is owing to the presence of a mature sector in the region. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to increasing number of exploration activities in the South China Sea and Southeast Asian countries.

Key players involved in the global oilfield stimulation chemicals market are The Dow Chemical Company, BASF SE, Clariant, DuPont, Chevron Phillips, Lubrizol Corporation, Schlumberger, Halliburton, Stepan Company, and Baker Hughes.

For instance, in September 2020, BASF SE expanded its production capacity with the installation of enhanced oil recovery polymer injection plants in Argentina.

Form-fill-seal Equipment Market continues to Expand with Bossar Packaging S.A partnered with ALLIEDFLEX Technologies to expand its operation in the North America region

The machine that is used to form fill seals has been around for many decades, but the improvements and variety of machines that are available today have made it less expensive and more accessible. The old machine that was used to seal documents had a paperclip on the end of the handle that could not be turned. There were also some people that would try to force the documents down into the machine and this would often leave a permanent indentation on the document.

Increasing demand from the pharmaceutical and healthcare sectors is expected to drive growth of the global form-fill-seal equipment market. The pharmaceutical and healthcare sectors have witnessed massive growth in both developed and emerging economies. According to the India Brand Equity Foundation (IBEF), the Indian pharmaceutical market was valued at US$ 20.03 billion in 2019, increasing from US$ 18.12 billion in 2018. According to the same source, the Indian healthcare market is expected to reach US$ 372 billion, increasing from US$ 193.83 billion in 2020, due to rising disposable income and increasing prevalence of lifestyle diseases. Form-fill-seal equipment is widely used in the healthcare and pharmaceutical sector for packaging various types of products that require a sterile environment. Hence, these factors are expected to drive growth of the global form-fill-seal equipment market. Furthermore, rapid growth of the aseptic packaging industry is expected to propel global form-fill-seal equipment market growth in the near future.

Low versatility in terms of packaging material and challenges associated with the extraction of air trapped in products during the sealing process is expected to hamper the global form-fill-seal equipment market growth in the near future. However, rapid growth of the flexible packaging sector combined with increasing demand for retort packaging can present lucrative growth opportunities for market players in the near future. Among regions, North America is expected to witness significant growth in the global form-fill-seal equipment market. This is owing to increasing demand for consumer-friendly & sustainable packaging in the region. Furthermore, Europe is expected to register a robust growth rate, owing to increasing demand for automated and efficient packaging machinery in the region.

Key companies involved in the global form-fill-seal equipment market are Winpak Ltd., Bossar Packaging S.A, HDG Verpackungsmaschinen GmbH, Triangle Package Machinery Company, Rees Machinery Group, Ossid LLC, Sacmi Imola S. C., Nichrome Packaging Solutions, Haver Continental Ltd, Chung Shan Machinery Works Co Ltd, Mega Plast GmbH, and Busch Machinery, Inc.

For instance, in February 2020, Bossar Packaging S.A, a provider of form-fill-seal equipment, partnered with ALLIEDFLEX Technologies, Inc. to boost its operation in North America.

The Global Anti-Snoring Treatment Market Continues To Grow Owing To the Growing Incidence of Snoring, Other Sleep-Related Disorders, and Consumption of Drugs and Alcohol Worldwide

Anti-snoring treatment is a way to keep the air passage of the body open when the individual is asleep. In simpler terms, this means that it is a device that is specially designed to keep the airway open so that the individual does not experience snoring while being asleep. In some cases, it's a mouthpiece that goes over the teeth to prevent from snoring when asleep. For other cases, it may be something else like a chin strap that holds the jaw up during sleep, or it could be an electronic device that makes noise to distract the sleep.

When someone is asleep, their mouth is completely closed, and this causes air to hit the tongue and throat as it passes by, vibrating, causing a sound known as snoring. Now when the airway is partially open because of some obstruction or some slight movement, this too vibrates and makes a very loud noise. This can easily be avoided by simply clearing the airway before going to bed.

Market Dynamics

The main factor driving the growth of the anti-snoring treatment market is the increased rate of drug and alcohol intake. For instance, according to RAND Corporation, there is approximate spending of US$ 100 billion on drugs annually in the U.S. According to National Institute on Drug Abuse, over 70,000 Americans died from a drug overdose in 2019. The intake of high amounts and drugs and alcohol can lead to various physical issues, such as blockage of the nasal passage, which results in snoring. Moreover, unhealthy lifestyles such as high-calorie intake, obesity, and stress are estimated to propel the growth of the anti-snoring treatment market.

However, absence of knowledge related to proper treatments and the costly anti-snoring surgeries and devices are the main restraining factor hindering the growth of the anti-snoring treatment market.

This market is distributed in five regions that include North America, Asia-Pacific, Europe, Africa, and the Middle East, and Latin America. Among these, North America is estimated to hold a significant share of the anti-snoring treatment market owing to the high consumption of drugs and alcohol and the increase of snoring disorder in the region. For instance, according to Johns Hopkins Medicine, an estimate of over 45% of U.S. adults snore occasionally while 25% do it regularly.

The anti-snoring treatment market in the Asia Pacific is estimated to witness significant growth owing to the prevalence of sleeping disorders in the region and low-cost surgeries and devices.

Competitive Analysis

Key companies in the global anti-snoring treatment market are Airing CPAP, ResMed, Inc., AccuMED Corp., Sleep Well Enjoy Life, Ltd., Sleeping Well, LLC, Fisher & Paykel Healthcare, Apnea Sciences Corporation, and GlaxoSmithKline, plc.

In February 2021, the U.S. Food and Drug Administration approved the usage of eXciteOSA developed by Signifier Medical Technologies. This anti-snoring device zaps the tongue to reduce snoring frequencies.

High prevalence of skin cancer to foster the growth of the actinic keratosis market

 

The term "actinic keratosis" refers to a group of skin conditions, characterized by hyperpigmentation, hyper-pigmentation, or skin changes. This disease is caused by a buildup of a pigment called melanin in the epidermis. Melanin protects the skin from UV light and from infections. However, some types of skin overproduce melanin, which can lead to the development of actinic keratosis. There are several different conditions that can cause actinic keratosis. Skin disease, exposure to UV radiation, trauma, and certain drugs can also cause the condition.

The growing prevalence of actinic keratosis is a prime factor contributing to the growth of the actinic keratosis market. According to The Skin Cancer Foundation, 1 in 5 Americans will develop skin cancer by the age of 70. Actinic keratosis is the most common precancer; it affects more than 58 million Americans. It is one of the precancerous skin lesions diseases. Increasing awareness regarding the disease due to the growing number of campaigns that focus on raising awareness regarding the disease. The development of healthcare infrastructure especially across emerging economies due to increasing investment is also fostering the growth of the actinic keratosis market.

North America is projected to gain significant growth over the forecast period and this is attributed to the increasing cancer treatment spending in order to improve the treatment efficacy. According to the National Cancer Institute, Estimated national expenditures for cancer care in the United States in 2018 were $150.8 billion. In future years, costs are likely to increase as the population ages and more people have cancer. This is also attributed to the high prevalence of skin cancer in the region.

Key Developments:

In December 2020, Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis. Klisyri® (tirbanibulin) is a novel microtubule inhibitor, indicated for the topical treatment of actinic keratosis (AK) on the face or scalp
In March 2020, Almirall applies for European approval for a new actinic keratosis option. The European Medicines Agency will review submission from dermatology specialist Almirall (ALM: MC) to market tirbanibulin, also known as ALM14789, for the treatment of actinic keratosis
In December 2017, Almirall, S.A (ALM), a global skin-health-focused pharmaceutical company announced an agreement with Athenex, Inc. for the treatment of cancer and related conditions, to further develop and commercialize KX2-391 for the treatment of actinic keratosis and other skin conditions.

Increasing integration of Healthcare IT System to Foster the Growth of the Medical Computer Cart Market

 

Medical computer carts provide total instrumentation flexibility, high-speed data transfer rates, and complete instrumentation compatibility with other brands and applications. Medical computer carts help medical professionals manage their workflow while reducing training costs, reducing operating costs, and simplifying patient care. A medical computer cart solution can be implemented at any level of the healthcare operation and is designed to seamlessly coordinate with existing medical office software systems. The carts are available for use in most medical facilities including rehabilitation clinics, doctor offices, and surgical centers, as well as pharmacies and hospital outpatient departments.

Increasing use of medical carts across a wide range of applications such as medical recording, training, charting, nursing education, and medicine dispensing is predominantly fueling the growth of the medical computer cart market. Growing global healthcare spending by the government is again fueling the growth of the market. According to the World Health Organization, global spending on health continues to rise. It was US$ 7.8 trillion in 2017 or about 10% of GDP and $1,080 per capita – up from US$ 7.6 trillion in 2016. Moreover, the growing incidence of musculoskeletal injury (MSI) coupled with the increasing adoption of electronic medical records (EMR) is further anticipated to propel the growth of the medical computer cart market.

The Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Continues To Grow Owing To the Demand from Cancer Institutes across the Globe for Carrying Out Targeted Therapies

 

Vascular endothelial growth factor (VEGF) antibodies act on the Enhancer RNAs (eRNAs) to enhance their growth factor binding abilities and increase their size and number. Vascular endothelial growth factor commonly referred to as vascular permeability protein is an indicator protein produced in vascular smooth muscle cells, which stimulates the proliferation of vascular tissue. To be more precise, VEGF antibodies consists of two subfamilies of vascular growth factors, the vascular-derived growth factor (VDG), and the platelet-derived growth factors (PDG). The primary function of VEGF antibodies in the body is to regulate vascular permeability, but it has also been found to stimulate cell growth and survival in many organs. Thus, it is useful in organ maintenance and repair. In addition, vascular endothelial growth factor (VEGF) antibodies has been shown to enhance wound healing in animal models and in vitro tests.

Market Dynamics

The main factor influencing the growth of the vascular endothelial growth factor (VEGF) antibodies is the increasing prevalence of diseases such as macular degeneration and cancer. For instance, according to the U.S. Cancer Organization, in 2020, numbers of new cancer cases were approximately 1.8 million among them death cases were approximately 606,520. The inclination towards targeted therapies is increasing owing to the lesser side effects of targeted therapies when compared with traditional therapies such as chemotherapy. Therapies present in the market have displayed better clinical results in cancer as well as in age-related macular degeneration (AMD). These have attracted the interest of manufacturers and investors towards the vascular endothelial growth factor (VEGF) antibodies market.

However, the high costs of these medicines, subsequent launches, and biosimilar research are the main restraining factors hindering the growth of the vascular endothelial growth factor (VEGF) antibodies market.

This market is distributed in five regions that include North America, Europe, Asia-Pacific, Middle East, and Africa, and Latin America. Among these North America is estimated to hold a significant share of the vascular endothelial growth factor (VEGF) antibodies market owing to the presence of key manufacturers in the region and the rapid expansion of cancer organizations. For instance, according to the American Cancer Society, as of 2019, there were 7 Basic Laboratory Cancer Centers, 13 Cancer Centers, and 51 Comprehensive Cancer Centers. In all counting the NCI designated places there are almost 1500 cancer centers in the U.S. In the Asia Pacific, the vascular endothelial growth factor (VEGF) antibodies market is estimated to witness significant growth owing to sophisticated insurance facilities and favorable governmental policies.

Competitive Analysis

Key players operating in the vascular endothelial growth factor (VEGF) antibodies market include ThromboGenics Inc, Ceres Oncology Pty Ltd, Valeant Pharmaceuticals, Regeneron Pharmaceuticals, Inc., Bayer Pharma AG, Eli Lilly and Company, Novartis, Exelixis Inc., and Genentech Inc.

In May 2018, U.S. FDA gave priority review status to Tecentriq that is manufactured by Roche for treating patients suffering from non-small and non-squamous lung cancer. Likewise in January 2018, European Commission granted approval for Bevacizumab manufactured by Avastin, for treating patients suffering from ovarian, cervical, kidney, glioblastoma, lung, and colorectal cancer.

The Global Porphyria Treatment Market Continues To Grow Owing To the Incidence Rate of Genetic Disorders and Demand from Healthcare Sectors across the World to Treat Patients Suffering From This Disorder

 

Porphyria treatment of all forms of porphyria involves addressing the underlying genetic defect and ensuring that the affected area of the liver is treated effectively so as to prevent further skin damage. Porphyria is a very rare genetic disorder that attacks the nervous system of the skin and can cause severe abdominal pain. Cells of patients suffering from porphyria are unable to alter the chemicals of the body known as porphyrins. The various forms that impact the central nervous system are sometimes called acute porphyria, due to the quick onset and brief duration of symptoms. Severe porphyria is characterized by chronic wasting syndrome (CMS) where the skin begins to thicken and eventually becomes leathery.

The main factor influencing the porphyria treatment market is the increase in the number of cases of porphyria. Even though the prevalence of the disease is still not clear to experts, the probability ranges from 1 in 500 to 1 in 50,000 individuals across the globe. For instance, according to the U.S. National Center for Biotechnology Information, porphyria is a very rare disease affecting less than 200,000 individuals. Acute porphyria occurs frequently in regions such as the U.K., Sweden, and Northern Europe. Growth in investments related to R&D sectors for the development of better treatment options is expected to propel the growth of the porphyria treatment market. Additionally, government initiative especially in emerging economies and expansion of health care sectors is expected to augment the market growth.

However, less knowledge and uncertainty of the disease are the main restraining factor hindering the market growth of porphyria treatment.

This market is distributed in five regions that include North America, Europe, Asia-Pacific, Middle East, and Africa, and Latin America. Among these North America and Europe jointly is estimated to hold a significant share of the porphyria treatment market owing to the presence of key industry players introducing new products and initiating R&D processes for better product development. The spread of healthcare sectors in these regions is also expected to drive the growth of the porphyria treatment market. For instance, according to the U.S. National Institutes of Health, Porphyria cutanea tarda (PCT) is a very prevalent disease in the U.K. affecting 1 in every 10,000 people or 2 in every 5 million individuals in the region. The porphyria treatment market in the Asia Pacific is estimated to witness significant incidence owing to the growth in awareness related to porphyria and the extensive patient population. Additionally, favorable government initiatives to support the healthcare infrastructure are expected to propel the growth of the porphyria treatment market in the region.

Key players operating in the porphyria treatment market include Bio-Rad Laboratories, Inc., ACON Laboratories, Inc., Dahaner, Siemens AG, Hoffmann-La Roche Ltd, Sysmex Corporation and ARKRAY, Inc.

In November 2019, the U.S. Food and Drug Administration approved GIVLAARI injection for treating adults suffering from acute hepatic porphyria (AHP).

The Global Medical Nutrition Market Continues To Grow Owing To The Rising Demand From Healthcare Sectors As A Nutrition Supplement For Treating Patients Suffering From Metabolic Diseases And Obesity

 

Medical nutrition is a kind of treatment especially for those who are overweight. It is for those with certain medical conditions as well. During treatment, the patient works closely with a licensed dietitian to create a personalized nutrition program just for them. A licensed dietitian can work with patients to solve their problems regarding their health.

During the process, individuals will be advised and counseled on how to change their lifestyle habits. This includes changing their eating habits and gradually replacing fatty foods with healthier choices such as fruits and vegetables. As a result, their intake of food will be less in quantity and more appropriate for the particular condition. The dietitians are there to help them and keep track of their progress. Once the individuals have reached their target weight, the dietitians can assist them in creating and implementing maintenance plans to maintain it.

Market Dynamics

The main factor influencing the medical nutrition market is rapid product launches by key players. The growing number of products launched by manufacturers in the market is expected to boost the market growth. For instance, in July 2019, Baxter Baxter International Inc. introduced Finomel, which is a ready-to-use bag with three chambers that can be used for parenteral nutrition in Europe. Moreover, partnerships and acquisition among market players are expected to augment the growth of the medical nutrition market. For instance, in 2019, Wellmetric and DSM joined forces to explore the efficacy of Wellmetrix's diagnostic platform for performing point-of-need and non-invasive measurements of health biomarkers.

However, the complications and side effects caused by medical nutrition products is the main restraining factor hindering the market growth. Moreover, lack of awareness of healthcare diet and adequate nutrition balance in middle and low-income groups is another factor hindering the growth of the medical nutrition market.

This market is distributed in five regions that include North America, Europe, Asia-Pacific, Africa, and the Middle East, and Latin America. Among these, North America is expected to hold a bigger share of the medical nutrition market owing to the rise of metabolic disorders and obesity in the region. For instance, according to the Trust for America's Health, in 2020 the U.S. adult obesity rate was 42.4% and this is the first time that the nation's obesity rate has passed the 40% mark and has revealed the obesity crisis of the region. The medical nutrition market in the Asia Pacific is estimated to witness significant growth owing to the prevalence of key players in the region and health campaigns by government and private authorities to make people aware of obesity and to treat it healthily.

Competitive Analysis

Major players operating in the global medical nutrition market include DSM, BASF SE, Sun Pharmaceuticals Inc., Fresenius Kabi AG, GlaxoSmithKline Plc, Nestlé, Danone S.A, Baxter, and Abbott.

In September 2020, Baxter announced that Clinimix E and Clinimix have been approved for treating patients who require parenteral nutrition. Likewise in April 2020, AYMES International launched a vegan oral medical nutrition with a product name AYMES ActaSolve Smoothie, as a dietary supplement for people suffering from malnutrition.

Increasing Prevalence of Chronic Eye Diseases to Augment the Tonometers Market Growth

 

Tonometers, also known as hand-pieces, are mechanical devices that measure eye pressure and the flow of fluid through the cornea, lens and retina. They play an important role in various fields of medicine such as ophthalmology, optometry, clinical measurements, and medical lasers. The most common use of a tonometer is for measuring intraocular pressure or the pressure of the fluid within the eye, which occurs during normal vision.

Other uses include in the diagnosis and treatment of certain eye diseases, for obtaining an accurate reading of the pressure of tears during the night, and to prevent or detect possible internal bleeding or infections in the eye. Tonometry is a diagnostic test primarily used to detect glaucoma, one of the leading cause of irreversible blindness worldwide.

Market Dynamics:

Increasing incidence or prevalence of chronic eye diseases such as glaucoma is expected to propel the tonometers market growth. For instance, according to the Centers for Disease Control and Prevention, more than 3 million people in the United States have glaucoma. It is the second leading cause of blindness worldwide after cataract. Around 50% of people with glaucoma don’t know they have the disease.

Moreover, growing geriatric population and increasing prevalence among people is expected to augment the growth of the tonometers market. For instance, according to World Health Organization (WHO), the world's population aged 60 years and older is expected to total 2 billion by 2050, up from 900 million in 2015.

However, the risks associated with the use of tonometer is expected to restrain the growth of the tonometers market. For instance, the use of contact tonometer may lead to risk of infection or corneal abrasion, while non-contact tonometer have low accuracy level in the measurement of the intraocular pressure.

Competitive Analysis:

Major players operating in the tonometers market are Reichert Technologies, NIDEK CO., HAAG-STREIT GROUP, Topcon Corporation, Icare Finland Oy (Icare Finland is a part of Revenio Group Corporation), and Canon Inc.

Major players in the market are increasingly focused on launching new and innovative products to strengthen their product portfolio or to enhance their market presence. For instance, in May 2020, Icare USA launched ic200 handheld tonometer for intraocular pressure measurement. It measures intraocular pressure without anesthetic drops, air puffs, or specialized skills.

Moreover, in 2018, Keeler launched wireless non-contact tonometer, TonoCare, that uses soft air puff technology, meaning it doesn’t require disposable pins.

Growing aging population along with the increasing prevalence of osteoarthritis and rheumatoid arthritis is propelling growth of walking assist device market

 

The main driving forces propelling the demand for walking assist devices are the surging demand for therapeutic rehabilitation equipment, the ever-increasing incidences of arthritis and rheumatism, and the steadily increasing aging population. In fact, as people grow older, many of them may be facing difficulties in walking long distances without feeling the pain. This can lead to serious problems such as loss of mobility, walking accidents, or even the inability to carry out their day to day activities.

The increasing aging population is a key factor fueling growth of the walking assist device market. According to the United Nation, in 2019, there were 703 million persons aged 65 years or over in the global population. This number is projected to double to 1.5 billion in 2050. The rise in road accidents is again expected to augment growth of the walking assist device market . Around 1.35 million people die each year as a result of road traffic crashes. 93% of the world's fatalities on the roads occur in low- and middle-income countries, even though these countries have approximately 60% of the world's vehicles. Moreover, advancement in the walking assist device is further projected to foster market growth over the forecast period.

North America is expected to gain significant growth over the forecast period and this is attributed to the high presence of the geriatric population in the region. According to the U.S. Census Bureau, there were

40.3 million U.S. residents 65 years and older in the 2010 Census and more than 54 million on July 1, 2019. Moreover, the high prevalence of osteoarthritis and rheumatoid arthritis in the region is further projected to foster the regional market growth over the forecast period. According to the Centers for Disease Control and Prevention, with the aging of the US population, the prevalence of doctor-diagnosed arthritis is expected to increase in the coming decades. By the year 2040, an estimated 78.4 million (25.9% of the projected total adult population) adults aged 18 years and older will have doctor-diagnosed arthritis

Key Developments:

In January 2019, Honda has announced that it has received Premarket Notification from the U.S. Food and Drug Administration (FDA) for its Walking Assist Device, developed to support people with reduced walking abilities.
In September 2017, Honda Australia launches it's first-ever brand TVC celebrating Honda’s innovative, human-centric philosophy to help stroke victims walk again.
In February 2019, Honda R&D Americas, Inc. announced that they and The Ohio State University have been awarded a grant by The Michael J. Fox Foundation (MJFF) to research the safety and potential positive impact that Honda's Walking Assist Device could have in helping people with Parkinson's disease (PD).

Increasing Prevalence of Peripheral Vascular Disease (PVD) to Augment the Blood Flow Measurement Devices Market Growth

 

Blood flow measurement devices help in understanding the nature of blood flow such that the volume of blood supplied to various organs and abnormal changes in blood flow velocity. On the basis of products, these devices are divided into electromagnetic, laser Doppler, and ultrasonic Doppler blood flow meters.

Market Dynamics:

Increasing prevalence of peripheral vascular disease (PVD) combined with growing geriatric population is expected to augment the blood flow measurement devices market growth. For instance, around 6.5 million people age 40 and older in the United States have PVD, according to the Centers for Disease Control and Prevention (CDC).

Moreover, increasing research and development activities, as well as continuous advancements in the blood flow measurement devices are expected to propel the growth of the blood flow measurement devices market. For instance, in Jan. 2021, Valencell announced the development of an upgraded biometric blood pressure measuring technology for healthcare wearables that does not require calibration or a worn cuff.

Increasing prevalence of cardiovascular diseases and increasing adoption of innovative devices by the major players are also expected to fuel the growth of the market. For instance, in Jan. 2021, Sky Medical Technology announced that Luton and Dunstable University Hospital are the first NHS hospital in the South East to deploy the innovative geko device for VTE prevention in immobile acute stroke patients who cannot be prescribed the current standard of care.

Increasing clinical applications of blood flow measurement devices are expected to offer lucrative growth opportunities for players the market.

However, high cost of devices, stringent regulations, slow approval processes, and high investment for R&D and clinical trials are some of the factors expected to restrain the blood flow measurement devices market growth.

Competitive Analysis:

Key players operating in the blood flow measurement devices market are Compumedics Ltd., Carolina Medical Plc., Ace Medicals, Flowtronics Inc., Elcat GmBH, Cook Medical, D E Hokanson Inc., AKW Medicals Inc., Biomedix Inc, Medtronics, Transonic Systems, Perimed AB, Moor Instruments Ltd., Medistim ASA, GF Health Products, Deltex Medical Ltd., Arjo, Cook Medical Inc., Compumedics Ltd., and Atys Medical.

Key players in the market are focused on launch and approval of new devices to enhance their market presence or to strengthen their product portfolio. For instance, in January 2020, Cook Medical received FDA (Food and Drug Administration) authorization to market new EchoTip Insight Portosystemic Pressure Gradient Measurement System, an endoscopic ultrasound device to measure portal hypertension, in the United States.

Global Food Stabilizer Market Continues to Grow Rapidly as Major Industry Leader Glanbia Nutritionals Completes Acquisition of Watson Inc., a provider of custom bakery ingredients

 

A stabilizer is an additive to food that helps to preserve its structure. Its primary application includes preventing oil, water emulsions from separating in products including salad dressing. These food stabilizers are a group of compounds that are responsible for adding viscosity to the mix. There are two types of food stabilizers namely artificial stabilizers and natural stabilizers.

The multi-functionality of food stabilizers in different food & beverage products is expected to drive growth of the global food stabilizer market during the forecast period. The beverage stabilizers prevent degradation, sedimentation, and turbidity during beverage processing and also provide stability to beverages. For instance, Xanthan gum is used as a stabilizer, suspending agent, thickener, and emulsifier. Furthermore, stabilizers in food products help to increase the stability and thickness by helping foods remain in an emulsion and maintain physical characteristics. Many low-fat foods require stabilizers. Thus, these factors are expected to drive growth of the global food stabilizer market during the forecast period. Furthermore, the increase in demand for customized products is expected to boost the global food stabilizer market growth over the forecast period. Many products convenience food products or customized beverages require food stabilizers to extend the life of the product. Hence, such factors are expected to boost market growth in the near future. Moreover, rapid growth in demand for naturally-sourced ingredients is expected to accelerate the global food stabilizer market growth over the forecast period.

However, the stringent legal framework in the food & beverage industry combined with rising consumer demand for clean label products is expected to boost the global food stabilizer market growth over the forecast period. Besides, rapid growth of emerging markets and increasing investment for research and development activities to develop novel products can present lucrative growth opportunities in the global food stabilizer market during the forecast period. Among regions, Europe is expected to hold a dominant position in the global food stabilizer market during the forecast period. This is owing to the presence of a large food processing base across the region. Asia Pacific is expected to register a robust growth rate over the forecast period, owing to increasing disposable income and reside demand for processed food in emerging economies such as India and China.

Key players operating in the global food stabilizer market are Glanbia Nutritionals, Deosen Biochemical Ltd., E. I. DuPont de Nemours and Company, Archer Daniels Midland Company, Kerry Inc., Associated British Foods Plc., Hansen A/S, Koninklijke DSM N.V., Cargill, Inc., Holton Food Products, Chemelco International B.V., Tate & Lyle, and Palsgaard.

For instance, in February 2019, Glanbia Nutritionals, a subsidiary of Glanbia plc, acquired Watson Inc., a U.S.-based manufacturer of custom bakery ingredients.

Changes in Automotive Industry, Majorly Due To Covid-19, May Impact Growth of Automotive Sheet Metal Components Market

 

The automotive sheet metal components market is expected to grow at a healthy CAGR as companies discover ways to reduce costs while maintaining quality. While many companies have already announced plans to cut manufacturing and service staff, the supply chain will remain largely intact because the supply of these materials is tied down in many cases by a complex array of suppliers. The changes in the industry, majorly due to Covid-19, however, are starting to affect the cost of automotive sheet metal components.

Market Dynamics

Increasing launch of hybrid and electric vehicles is expected to propel growth of the automotive sheet metal components market. For instance, in January 2020, Great Wall Motor, a China-based automobile manufacturer, announced to launch its electric car Ora R1 in India in 2020.

Increasing demand for light-weight automobiles is expected to offer lucrative growth opportunities for players in the automotive sheet metal components market.

Among regions, Europe is expected to witness sluggish growth in the automotive sheet metal components market, owing to significant decline in the automotive sector. For instance, according to the Society of Motor Manufacturers and Traders, the new car registrations in the U.K. decreased by 44% in March 2020 compared that in March 2019. Moreover, North America is also expected to witness significant decline in the automotive sheet metal components market, as sales of motorcycles and cars witness downward trend. For instance, Yamaha Motor Co. has projected that the company’s motorcycle sales will drop 4.7% to 60,000 units in North America in 2020. During the fiscal year ended December 31, 2019, motorcycle sales dropped 6.3% to 63,000 units year over year. Similarly, Harley-Davidson Inc. reported that retail sales volumes dropped 4.3% in 2019 from 2018.

Competitive Analysis

Major players operating in automotive sheet metal components market include, Larsen Manufacturing, General Stamping & Metalworking Inc., Aleris Corporation, Mayville Engineering Company Inc., The Cramer Group, O’Neal Manufacturing Services, Omax Auto Limited, Novelis, Inc., Frank Dudley Ltd., Jobro Sheet Metal Technology AB, Amada Co. Ltd. And Paul Craemer GmbH.

March 2019: General Stamping & Metalworking Inc., partnered with City of South Bend’s On Demand Program that supports local employers in helping build skill sets of their employees. Through General Stamping & Metalworking Inc.’s partnership with the City of South Bend, Washington, U.S., 13 GSM employees received the opportunity to attend training aimed at expanding lean and manufacturing skill sets.

Increasing Launch of Satellites to Provide Satellite Internet Access to Augment Growth of the Satellite Telephones Market

 

A satellite telephone, sat phone or satellite phone, is a kind of communication device that links to the telephone network or other phones by radio via orbiting satellites rather than terrestrial cell sites. Satellite phones can be used in a variety of ways and the services that are offered depend on the satellite service provider. A common type of communication service provided is voice over internet protocol (VoIP). This service enables users to make voice calls to long distances with regular land lines and other regular devices such as cordless telephones.

There are also other types of satellite phone services available. Satellite phones offer International Short Message Service (ISMS) which is similar to International Dialup Service (IDS), but with fewer data services. International Long Distance Phone (ILDFS) is another form of ILS. It is also similar to Global Positioning System (GPS) but only offers data services. Satellite phones also offer data services such as voice mail, fax, web browsing, and access to Internet data services such as streaming video and picture services.

Market Dynamics

Increasing launch of satellites to provide satellite Internet access is expected to propel growth of the satellite telephones market. For instance, in May 2019, SpaceX launched the first 60 operational satellites of its network of satellites called Starlink that is tasked to provide satellite Internet access.

Moreover, increasing adoption of satellite phones is also expected to aid in growth of the market. For instance, in June 2020, Thuraya, the mobile satellite services subsidiary of the UAE’s Al Yah Satellite Communications Company (Yahsat), announced that the company is providing always-on satellite connectivity to Dubai Corporation for Ambulance Services through its partner, Cygnus Telecom.

Launch of satellites for mobile communication is expected to offer lucrative growth opportunities for players in the satellite telephones market. For instance, in November 2020, China launched its 34th satellite in 2020. The Tiantong-1 (02) mobile communications satellite went into orbit above the Earth last week, carried there into a geostationary transfer orbit on a Long March 3B rocket.

Competitive Analysis

Major players operating in the satellite telephones market include, Inmarsat, Iridium Communications Inc., Globalstar, TerreStar, Thuraya, Nice Trip, and SPOT Global Phone.

Major players operating in the satellite telephones market are focused on launching new products to expand their product portfolio. For instance, in October 2020, Iridium Communications Inc. launched new, special edition, Iridium Extreme satellite phones — Iridium Extreme Safety Yellow and Iridium Extreme Sporting Camo.

Lack of Awareness about Digital Door Lock System to Hinder the Growth of Digital Door Lock System Market

 

Digital door lock systems refer to electronically operated physical access systems that have gained significant traction in the past few years due to growing concerns for the safety and security of organizational, private, and personal assets. Digital door lock systems are widely used in enterprises and other businesses to keep track of the information about a person entering or exiting a workplace. Digital door locks provide a low cost, easy to install security solution that requires a reliable means of access control but where the allocation of cards or keys is unpractical due to the volume of entry and exit into the building.

Moreover, digital door locks provide keyless access to schools, homes, and business premises without always having a set of keys. There are two main types of digital lock such as Electronic and Mechanical. They are available in multiple options depending on the security requirements of the user, such as access based on security tokens, passwords, numeric code, passphrases, different types of biometrics, and radio frequency identification devices. Furthermore, the use of smartphones as a means of gaining entry is among the major solutions gaining traction for residential and other end-user applications. The availability of large-scale options and the high level of security offered by these solutions are expected to drive market growth.

Increasing cases of crime, theft, and home invasion worldwide are among the leading causes of market growth. According to the Federal Bureau of Investigation (FBI), in 2019, around 1,117,696 burglaries occurred in the United States. Moreover, around 38% of assaults and 60% of rapes occur during home invasions. In the U.S., there is one burglary every 13 seconds and around 2.3 and 2.6 million robberies every year. The above-mentioned factors are expected to increase the demand for digital door lock systems. However, the lack of awareness among people about digital door lock systems is expected to hamper the growth of the digital door lock system market.

In terms of geography, the digital door lock system market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa. Based on type, the digital door lock system market is segmented into biometrics and keypad locks. Moreover, the increasing number of terrorist activities in emerging economies and a large number of infrastructure investment activities are expected to generate significant growth opportunities for the market. Key players active in the digital door lock system market are Panasonic Corporation, Hitachi Ltd., Godrej & Boyce Manufacturing Company Ltd., Allegion, Nestwell Technologies, Cisco Systems, ABB, etc.

Global Rigid Packaging Market Continues to Expand as Major Market Leader Alpla Group acquires Amcor Limited’s plastic plant of PET bottles in India to strengthen its Foothold

 

Rigid packaging is simply lightweight pouches or bags sealed with pressure or heat seal. The most obvious advantage of rigid packaging is that it is very lightweight and very durable, offering high protection against damage. The thickness of a rigid package is an important factor to consider when considering the advantages and disadvantages of both types of packaging.

High growth in the logistics and transportation sector is expected to drive growth of the global rigid packaging market during the forecast period. The logistics and transportation sectors have witnessed massive growth in both developed and emerging economies. According to the India Brand Equity Foundation (IBEF), the Indian logistics market is expected to reach US$ 215 billion by 2020, registering a CAGR of 10.5%. Rigid packaging is a critical element in the transportation and logistics application. It offers adequate protection & durability during transportation along with a variety of substrates, shapes, and enhanced recycling capabilities. Thus, these factors are expected to drive growth of the global rigid packaging market during the forecast period. Furthermore, rapid growth of the e-commerce industry is expected to propel the global rigid packaging market growth over the forecast period. According to the U.S. Department of Commerce, e-commerce sales in the U.S. in the third quarter of 2020 reached US$ 199.4 billion. Moreover, rising consumer goods demand and improving package recycling rates are expected to boost the market growth over the forecast period.

However, rising adoption of flexible packaging materials combined with fluctuating raw material prices is expected to hinder the global rigid packaging market growth over the forecast period. Among regions, Asia Pacific is expected to witness significant growth in the global rigid packaging market during the forecast period. This is owing to a rapid expansion of the food & beverage and pharmaceutical sectors in the region. Emerging economies such as India and China are expected to leaders in goods export in the region, thereby driving the regional market growth. Furthermore, North America is expected to register a robust growth rate over the forecast period, owing to increasing use of bioplastic as a raw material in rigid packaging, owing to stringent guidelines on carbon emission.

Key companies involved in the global rigid packaging market are Amcor Limited, Mondi Group, Bemis Company, RESILUX NV, Georgia-Pacific LLC, DS Smith plc, Sealed Air Corporation, Holmen AB, Reynolds Group Holdings Limited, and Berry Plastics Corporation.

For instance, in September 2020, Alpla Group, a provider of plastic packaging solutions, acquired Amcor Limited’s plastic plant of PET bottles in India.

Intracranial Pressure Monitoring Devices Market to Witness Massive Expansion as Incidence of Traumatic Brain Injuries and Neurodegenerative Disorders Continues to Increase

 

Intracranial pressure (ICP) monitoring refers to a diagnostic test, which uses a device that helps doctors to determine cerebrospinal fluid (CSF) pressure is whether low or high. The monitor senses the pressure inside the skull and sends measurements to the recording device. ICP monitoring devices are typically used to examine brain trauma and head injuries. It is also used to examine neurodegenerative disorders such as Parkinson’s and Alzheimer's.

Increasing cases of head and brain injuries are expected to drive growth of the global intracranial pressure monitoring devices market during the forecast period. According to the Centers for Diseases Control and Prevention (CDC), traumatic brain injury (TBI), is one of the major causes of death and disability in the U.S. According to the same source, from 2006 to 2014, TBI-associated hospitalization and deaths increased by 53%, whilst around 155 people die each year from TBI-related injuries in the U.S. According to the CENTER-TBI, around 50 million new cases of TBI are recorded globally, while around 57,000 TBI-related deaths are recorded in the European Union (EU). Such a massive incidence of TBI has led to high demand for intracranial pressure monitoring devices. These devices enable doctors to determine if the cerebrospinal fluid is high or low. Thus, these factors are expected to drive growth of the global intracranial pressure monitoring devices market during the forecast period. Moreover, rising prevalence of neurodegenerative disorders is expected to boost the global intracranial pressure monitoring devices market growth over the forecast period. According to the Alzheimer’s Association, over 5 million U.S. citizens of all ages suffer from Alzheimer’s, a neurodegenerative disorder.

However, the lack of skilled personnel for handling equipment combined with high procedural cost of these devices is expected to restrain growth of the global intracranial pressure monitoring devices market growth over the forecast period. Besides, growing awareness and technological advancements in intracranial pressure monitoring devices can present lucrative growth opportunities in the near future. Among regions, North America is expected to witness significant growth in the global intracranial pressure monitoring devices market during the forecast period. This is owing to the presence of robust healthcare infrastructure and early adoption of advanced ICP monitoring devices across the region. Moreover, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to proactive initiatives undertaken by government authorities and the presence of well-established hospitals in the region.

Key companies involved in the global intracranial pressure monitoring devices market are Medtronic plc, Natus Medical Incorporated, Codman & Shurtleff Inc., Spiegelberg GmbH & Co. KG, RAUMEDIC AG, Integra LifeSciences Corporation, Sophysa Ltd, and Orsan Medical Technologies.

For instance, in April 2019, Integra LifeSciences Corporation introduced the new Codman Specialty Surgical Product CereLink Intracranial Pressure (ICP) Monitoring System.

Extracorporeal Membrane Oxygenation System Market is expanding rapidly as Fresenius Medical Care North America Receives the U.S. FDA Clearance for its ECMO System

 Extracorporeal membrane oxygenation (ECMO) system is a life-support machine for people who have severe and life-threatening diseases of the heart and lungs. ECMO systems replace the function of lungs and hearts in the intensive care units (ICU). It is typically used to help people whose lungs cannot provide adequate oxygen to the body when extra oxygen and whose lungs cannot get rid of carbon dioxide.

Increasing prevalence of cardiovascular and respiratory diseases is expected to drive growth of the global extracorporeal membrane oxygenation system market during the forecast period. According to the World Health Organization (WHO), around 31% of all deaths, which is 17.9 million worldwide are due to cardiovascular diseases (CVD). Moreover, around 85% of all CVD deaths are due to strokes and heart attacks. According to the WHO, around 65 million people suffer from the chronic obstructive pulmonary disease (COPD), while 3 million die each year. Extracorporeal membrane oxygenation system plays a critical role in CVD diseases where blood is pumped outside of the body to a heart-lung machine, which removes carbon dioxide and sends oxygen-filled blood back to tissues in the body. Thus, these factors are expected to drive growth of the global extracorporeal membrane oxygenation system market during the forecast period. Furthermore, increasing number of ECMO centers is expected to propel the global extracorporeal membrane oxygenation system market growth over the forecast period.

However, the high cost of ECMO and lack of skilled personnel operating ECMO is expected to hinder the global extracorporeal membrane oxygenation system market growth over the forecast period. Besides, rising survival rates with ECMO can present significant growth opportunities in the global extracorporeal membrane oxygenation system market in the near future. Among regions, North America is expected to witness significant growth in the global extracorporeal membrane oxygenation system market during the forecast period. This is owing to increasing prevalence of diseases and proactive government support for quality healthcare across the region. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to robust economic development in emerging economies such as Japan, India, and China in the region.

Key companies involved in the global extracorporeal membrane oxygenation system market are Alung Technologies Inc., Xenios AG, Eurosets, Abbott Laboratories, Getinge AB, Terumo Medical Corporation, Livanova plc, Nipro Medical Corporation, Medtronic plc, and Microport Scientific Corporation.

For instance, in February 2020, Fresenius Medical Care North America received the U.S. Food and Drug Administration (FDA) approval for Novalung, an ECMO system indicated for acute respiratory or cardiopulmonary failure.

Medium-chain Triglycerides Market; Medium-chain Triglycerides Are in High Demand, Here's Why

 

Medium-chain triglycerides (MCTs) are saturated fats and are made up of medium-chain fatty acids with carbon chains. MCTs are man-made fats produced by processing palm kernel oils and coconut. They are readily available in various foods such as yogurt, butter, milk, cheese, coconut oil, and palm kernel oil. Medium-chain triglycerides are used in various applications due to their health benefits such as infant nutrition, dietary supplements, medicinal products, and personal care products. Moreover, they can treat celiac disease, diarrhea, liver disease, and many others. Medium-chain triglycerides are widely used in applications such as nutritional diet, personal care, infant formula, sports drinks, etc.

Rising health awareness and large populations in some emerging economies such as the Asia Pacific have increased the diagnosis of digestive disorders. Around 60 to 70 million people in the United States were affected by digestive disorders (such as steatorrhea, Crohn’s disease, celiac disease, diarrhea, etc.), according to the National Institute of Diabetes and Digestive and Kidney Diseases. Moreover, medium-chain triglycerides are prescribed for malnourished children to enhance body development. Around 45% of deaths among children under 5 years of age are linked to undernutrition, according to the World Health Organization. Malnutrition refers to deficiencies, excesses, or imbalances in a person’s intake of energy and/or nutrients.

Moreover, increasing demand for MCTs from the food and beverage industry in developing countries, as well as expansion in the personal care sector, is expected to propel the market growth. The increase in demand for MCTs may be attributed to an increase in health concerns about dietary supplements. MCTs offer several benefits such as weight management by reducing the fats in the body. Furthermore, increasing demand for various products containing MCTs is also expected to drive the medium-chain triglycerides market. C8 is the most potent MCT available on the market today. For instance, in 2019, LifeSense launched a domestically manufactured C8 MCT oil supplement for dogs.

Medium-chain triglycerides are increasingly popular among consumers and product makers due to their ease of use as well as their health benefits. However, stringent government regulations, premium pricing, and lack of awareness in rural areas of emerging economies are major factors restraining the medium-chain triglycerides market growth, especially in the Asia Pacific. In terms of geography, the market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa. Moreover, increased adoption of MCTs by the medical applications for the treatment of various diseases has also fueled the growth of the medium-chain triglycerides market.

Increasing Prevalence of Dental Disorders to Augment Growth of Cone Beam Computed Tomography (CBCT) Market

 

Cone beam computed tomography is an imaging technique that consists of X-ray computed imaging where the X-rays reflect and diverge, creating a cone-shaped beam. The cones are formed as the rays are deflected by colliding with a mirror and the resulting image is viewed from the inside of the cone. Cone-beam computed imaging uses the power of a computer to create images using the principle of diffraction and is very efficient in obtaining high quality images.

Market Dynamics

Increasing prevalence of dental disorders is expected to propel growth of the global cone beam computed tomography (CBCT) market. For instance, according to the Centers for Diseases Control and Prevention’s Oral Health Surveillance Report, 2019, the prevalence of untreated tooth decay in primary teeth was 10% among children aged 2–5 years and 16% among those 6–8 years during 2011-2016. Moreover, approval and launch of new products is also expected to aid in growth of the market. For instance, in December 2018, EhmetDX, received FDA 510(k) clearance for its 3D CBCT positioning software. The software is used to guide the position of proton beams in patient treatments.

Increasing geriatric population is expected to offer lucrative growth opportunities for players in the global cone beam computed tomography (CBCT) market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Moreover, increasing adoption of CBCT is also expected to aid in growth of the global cone beam computed tomography (CBCT) market. For instance, in November 2020, The JSS Dental College and Hospital, JSS Academy of Higher Education and Research, Mysuru, India, procured a machine — Cone Beam Computed Tomography (CBCT), one of the most advanced technology in various fields of dentistry.

High cost of advanced equipment is expected to hinder growth of the cone beam computed tomography (CBCT) market. For instance, devices such as cone beam CT scan and lasers may cost anything from US$ 50,000 to US$ 120,000.

Competitive Analysis

Major players operating in the cone beam computed tomography (CBCT) market include, Carestream Health Inc., Dentsply Sirona, Genoray, Instrumentarium Dental Inc., Planmeca Oy, Ray Ltd., Gendex Dental systems, Brainlab AG, NewTom, Danaher Corporation, Vatech Ltd., J. Morita Corporation, Asahi Roentgen Ltd., and PreXion Inc.

March 2019: Planmeca Oy, introduced an advanced Planmeca Viso G5 in the Planmeca Viso family, which offers high CBCT image quality.

Increasing Prevalence of Cancer and HIV to Augment the Flow Cytometry Market Growth

 

Flow cytometry is a laser-based biophysical technology employed in protein engineering, biomarker detection, cell sorting, and cell counting. It is required to a conduct study related to the blood. Flow cytometry analyzes the chemical and physical characteristics of the particles present in the blood. It is used to diagnose health disorders such as HIV and cancer along with several applications in basic research, clinical trials, and clinical practice. Flow cytometry is widely used for evaluating peripheral blood, bone marrow, and other body fluids. Moreover, it provides rapid analysis of multiple characteristics of single cells. The process finds application in microbiology, immunology, hematology, cytology, and among other research fields.

The increasing prevalence of chronic diseases worldwide and the need for rapid, accurate, and sensitive prognosis techniques for disease validation are expected to propel the growth of the flow cytometry market. According to the World Health Organization (WHO), chronic diseases are the leading cause of death worldwide. Moreover, increasing technological advancements (as flow cytometry is quite an unexplored field) and the introduction of advanced methods such as improved cell sorting, higher resolution, rapid detection, and multifunctional analysis, ensuring enhanced efficiency in identifying and characterizing novel drugs are also expected to augment the market growth.

For instance, in 2017, the United States Food Drug and Administration (FDA) approved the use of a flow cytometer in the detection of lymphoma and leukemia cancer (blood cancer). In 2019, about 76,200 Americans were expected to be diagnosed with myeloma, lymphoma, or leukemia cancer, according to the Leukemia and Lymphoma Society. Moreover, in 2020, around 60,530 people are expected to be diagnosed with leukemia. Furthermore, the growing prevalence of cancer and HIV are expected to foster the flow cytometry market growth.

The rise in the development of new products is expected to create significant opportunities for the key players operating in the market. For instance, in 2019, Agilent Technologies launched the Agilent NovoCyte Advanteon flow cytometer at the International Society for Advancement of Cytometry. In terms of geography, the flow cytometry market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa. Key players are focused on launching technologically advanced products in the market. For instance, in 2019, Becton, Dickinson and Company (BD) launched BD an automated flow cytometer, FACSDuet to improve their efficiency by reducing errors. Furthermore, in April 2018, Merck launched a compact, customizable flow cytometer, CellStream Benchtop.

Increasing Focus on Aesthetic Appeal to Augment Growth of the Dental Bone Graft and Substitutes Market

 

The dental bone graft and substitutes market is growing exponentially in recent years. This can be attributed to increasing focus on aesthetic appeal and increasing dental visits. Demineralized bone matrix, allograft, xenograft, and synthetic bone graft substitutes form the product type segment in the market.

Market Dynamics

Increasing focus on aesthetic appeal is expected to propel growth of the dental bone graft and substitutes market. For instance, according to a 2018 survey by GlobalData, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week. Moreover, increasing number of dentist visits is also expected to aid in growth of the market. For instance, according to National Center for Health Statistics’ 2018 report, 84.9% of children aged 2-17 years visited a dentist in 2017, in the U.S.

High prevalence of dental disorders is expected to offer lucrative growth opportunities for players in the dental bone graft and substitutes market. For instance, according to the Centers for Diseases Control and Prevention’s Oral Health Surveillance Report, 2019, the prevalence of untreated tooth decay in primary teeth was 10% among children aged 2–5 years and 16% among those 6–8 years during 2011-2016. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.

Among regions, North America is expected to witness significant growth in the dental bone graft and substitutes market, owing to increasing approval and launch of new products. For instance, in July 2020, Baxter International Inc. received the U.S. FDA approval of Altapore Shape Bioactive Bone Graft — the latest addition to the company’s next-generation bone graft substitute product line.

Competitive Analysis

Major players operating in the dental bone graft and substitutes market include, Institut Straumann AG, Geistlich, DENTSPLY International, Zimmer Biomet, Medtronic Plc., BioHorizons IPH, Inc., ACE Surgical Supply Company, Inc., RTI Surgical, Inc., LifeNet Health, and Citagenix

Major players operating in the dental bone graft and substitutes market are focused on approval and launch of new products to expand their product portfolio. For instance, in September 2020, Spine Wave launched Tornado Bioactive Bone Graft Matrix, which complements Spine Wave’s recently launched Tempest Allograft Bone Matrix, and each of these technologies work seamlessly with the company’s GraftMag Graft Delivery System.

Advancement in the production of household detergent to increase market size of linear alkylbenzene sulfonate (LAS)

 

Linear alkylbenzene sulfonate (LAS) is one of the most popular synthetic surfactants which is prepared by sulfonating linear alkylbenzene (LAB). This product is a petrochemical derivative and it is majorly used in the production of detergent as well as various industrial cleaners’ products. Dish washing liquids, industrial cleaners, personal care products, and household detergents & cleaners are some of the major application areas of the linear alkylbenzene sulfonate (LAS).

Increasing demand for linear alkylbenzene sulfonate (LAS) from household detergent is propelling the market growth. Growing hygiene awareness coupled with the advancement in the production of detergent is again expected to accelerate the market growth. Also, the integration of AI in IoT in washing machines is contributing to the industrial expansion. Ongoing research and development activities in the field of high-efficient laundry detergent is again projected to propel the market growth of linear alkylbenzene sulfonate (LAS). Increasing demand for dishwashing liquids along with the growing popularity of personal care products such as shampoo, creams, lotions, shower gels, and hair conditioners are further estimated to uplift the market growth in the near future.

In addition to this, the high demand for cleaners from various industries is projected to bring new and profitable opportunities for the linear alkylbenzene sulfonate (LAS) market over the forecast period. On the other hand, strict rules and regulation associated with the production and use of linear alkylbenzene sulfonate is expected to hinder the market growth.

From the geographical point of view, the Asia Pacific is expected to exhibit significant growth over the forecast period and this is attributed to the increasing population coupled with the changing lifestyle of the consumers due to growing disposable income. According to the United Nation, the Asia and the Pacific region is home to 4.1 billion people or two-thirds of the world’s population. Also, rapid urbanization and industrialization in the region are further projected to propel the regional market growth of linear alkylbenzene sulfonate (LAS).